000 01455 a2200349 4500
005 20250515094644.0
264 0 _c20080205
008 200802s 0 0 eng d
022 _a1535-2900
024 7 _a10.2146/ajhp070300
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarides, Alexandra
245 0 0 _aComparisons of aprepitant and ondansetron.
_h[electronic resource]
260 _bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_cDec 2007
300 _a2422-4; author reply 2424-6 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAntiemetics
_xadministration & dosage
650 0 4 _aAprepitant
650 0 4 _aChemoprevention
_xstandards
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aHumans
650 0 4 _aMorpholines
_xadministration & dosage
650 0 4 _aOndansetron
_xadministration & dosage
650 0 4 _aPostoperative Nausea and Vomiting
_xprevention & control
650 0 4 _aTreatment Outcome
700 1 _aReiss, Theodore
700 1 _aLines, Christopher
700 1 _aMcKeon, Bernadette
700 1 _aDiemunsch, Pierre
773 0 _tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_gvol. 64
_gno. 23
_gp. 2422-4; author reply 2424-6
856 4 0 _uhttps://doi.org/10.2146/ajhp070300
_zAvailable from publisher's website
999 _c17545794
_d17545794